09. COPD, Emphysema, Chronic Bronchitis, Alpha-1 Antitrypsin Deficiency -> Adult -> Clinical Studies

Biomarker-Based Clustering of Patients with COPD and the Association with Lung Function, Dyspnea and Health Status

Presenter:
  • L. Vanfleteren
Session Number
C13
Session Title:
C13 - USING 'OMICS TO ENDOTYPE COPD
Session Type:
Mini Symposium
Authors
  • L. Vanfleteren
  • F. Franssen
  • N. Reynaert
  • S. Gaffron
  • M. Groenen
  • E. Wouters
  • M. Spruit

Previous Eposter
Can Adding Symptom and Cigarette Use Survey Questions Correctly Identify Those with Chronic Obstructive Pulmonary Disease (COPD)?

Next Eposters
Serum Amyloid A (SAA) in Stable COPD Patients Is Associated with the Frequent Exacerbator Phenotype
Reduced Pneumococcal Antibody Function Is Associated with Exacerbations of COPD in SPIROMICS
Evaluating Current Discharge Practices After Acute COPD Exacerbation for Areas of Improvement to Ensure Delivery of Quality Care
Burden of Respiratory Symptoms in Older Adults with Underdiagnosed and Misdiagnosed of COPD: Results from the Canadian Longitudinal Study of Aging
FOOTPRINTS® Study Methodology and Baseline Characteristics: A 3-Year Longitudinal Study to Phenotype Patients with COPD
A Predictive Model for COPD Exacerbations Using ProAir Digihaler: A 12-Week, Open‑Label Study
Biomarkers to Predict Forced Expiratory Volume in 1 Second (FEV1) Decline in Healthy Smokers and Early-Onset Chronic Obstructive Pulmonary Disease (COPD)
GDF-15, Pentraxin-3 and TIMP-1 Plasma Biomarkers Improve Risk Assessment for Mortality in Ambulatory Veterans with COPD
Cardiovascular Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Chronic Obstructive Pulmonary Disease (COPD): A 24-Hour Holter Monitoring Sub-Study of the ETHOS Trial
Chronic Obstructive Pulmonary Disease Plus (COPD+)® as a Friendly App for Patients with Chronic Obstructive Pulmonary Disease